Progressive neurodegeneration in human dorsal root ganglion from diabetes to painful neuropathy

Read full text
Authors: Ishwarya Sankaranarayanan, Khadijah Mazhar, Allison M Barry, Stephanie I. Shiers, Andi Wangzhou, Julia Regina Sondermann, Feng Xian, Nikhil Inturi, Michael A Wilde, Eric Meyers, Joseph B. Lesnak, Jayden O'Brien
+13 more Muhammad Saad Yousuf, Manuela Schmidt, Gregory O. Dussor, Erin Vines, Peter Horton, Anna M. Cervantes, Tariq Khan, Geoffrey Alexander Funk, Diana Tavares-Ferreira, PRECISION Human Pain Network, Patrick M. Dougherty, Michele Curatolo, Theodore J Price
Cited by: 1
References: 55

Abstract

Diabetic painful neuropathy (DPN) is characterized by neuropathic pain accompanied by loss of sensory function. We hypothesized that neurodegeneration in the dorsal root ganglion (DRG) could underlie DPN progression. To address this question, we performed multi-omic evaluation on DRGs from otherwise healthy organ donors, donors with diabetes but no neuropathy, and donors with clinically diagnosed DPN. We discovered that the first stages of neurodegeneration begin early in diabetes before the onset of DPN, with Nageotte nodule formation accompanied by apoptotic gene expression and decreased proportion of specific populations of A-fibers in DPN with remodeling of non-neuronal cells. Our findings define DPN as a neurodegenerative disorder of the DRG, identify molecular markers of disease stage, and highlight the need for early intervention to prevent irreversible neurodegeneration.

Fields of Study & Subjects

Pain Mechanisms and Treatments Nerve injury and regeneration Pain Management and Treatment

Publication details

Journal / source
bioRxiv (Cold Spring Harbor Laboratory)
Publisher
openRxiv
Publication date
20 January 2026
Language
EN
Document type
Preprint